|
1
|
Yonemura Y, Endou Y, Sasaki T, Hirano M,
Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M and Li Y:
Surgical treatment for peritoneal carcinomatosis from gastric
cancer. Eur J Surg Oncol. 36:1131–1138. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bozzetti F, Yu W, Baratti D, Kusamura S
and Deraco M: Locoregional treatment of peritoneal carcinomatosis
from gastric cancer. J Surg Oncol. 98:273–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoo CH, Noh SH, Shin DW, Choi SH and Min
JS: Recurrence following curative resection for gastric carcinoma.
Br J Surg. 87:236–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iwahana H, Yanagisawa K, Ito-Kosaka A,
Kuroiwa K, Tago K, Komatsu N, Katashima R, Itakura M and Tominaga
S: Different promoter usage and multiple transcription initiation
sites of the interleukin-1 receptor-related human ST2 gene in UT-7
and TM12 cells. Eur J Biochem. 264:397–406. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bergers G, Reikerstorfer A, Braselmann S,
Graninger P and Busslinger M: Alternative promoter usage of the
Fos-responsive gene Fit-1 generates mRNA isoforms coding for either
secreted or membrane-bound proteins related to the IL-1 receptor.
EMBO J. 13:1176–1188. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayakawa H, Hayakawa M, Kume A and
Tominaga S: Soluble ST2 blocks interleukin-33 signaling in allergic
airway inflammation. J Biol Chem. 282:26369–26380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trajkovic V, Sweet MJ and Xu D: T1/ST2-an
IL-1receptor-like modulator of immune responses. Cytokine Growth
Factor Rev. 15:87–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hentschke I, Graser A, Melichar VO, Kiefer
A, Zimmermann T, Kroß B, Haag P, Xepapadaki P, Papadopoulos NG,
Bogdan C and Finotto S: IL-33/ST2 immune responses to respiratory
bacteria in pediatric asthma. Sci Rep 7:43426. 2017. View Article : Google Scholar
|
|
9
|
Yamamoto M, Sato S, Hemmi H, Hoshino K,
Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K and
Akira S: Role of adaptor TRIF in the MyD88-independent Toll-like
receptor signaling pathway. Science. 301:640–643. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siede J, Fröhlich A, Datsi A, Hegazy AN,
Varga DV, Holecska V, Saito H, Nakae S and Löhning M: IL-33
receptor-expressing regulatory T cells are highly activated, Th2
biased and suppress CD4 T cell proliferation through IL-10 and TGFβ
release. PLoS One. 11:e01615072016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Vark LC, Lesman-Leegte I, Baart SJ,
Postmus D, Pinto YM, Orsel JG, Westenbrink BD, Brunner-la Rocca HP,
van Miltenburg AJM, Boersma E, Hillege HL, Akkerhuis KM; TRIUMPH
Investigators, ; et al: Prognostic value of serial ST2 measurements
in patients with acute heart failure. J Am Coll Cardiol.
70:2378–2388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ko FW, Yan BP, Lam YY, Chu JH, Chan KP and
Hui DS: Undiagnosed airflow limitation is common in patients with
coronary artery disease and associated with cardiac stress.
Respirology. 21:137–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang JF, Wang P, Yan YJ, Li Y, Guan MW,
Yu JJ and Wang XD: IL-33 enhances glioma cell migration and
invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB
pathway. Oncol Rep. 38:2033–2042. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jovanovic I, Radosavljevic G, Mitrovic M,
Juranic VL, McKenzie AN, Arsenijevic N, Jonjic S and Lukic ML: ST2
deletion enhances innate and acquired immunity to murine mammary
carcinoma. Eur J Immunol. 41:1902–1912. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang Y, Zhao L, Xiao H, Cook KM, Bai Q,
Herrick EJ, Chen X, Qin C, Zhu Z, Wakefield MR and Nicholl MB:
IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer. Med Oncol.
34:232017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshida K, Arai T, Yokota T, Komatsu N,
Miura Y, Yanagisawa K, Tetsuka T and Tominaga S: Studies on natural
ST2 gene products in the human leukemic cell line UT-7 using
monoclonal antihuman ST2 antibodies. Hybridoma. 14:419–427. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You Y, Bai F, Ye Z, Zhang N, Yao L, Tang Y
and Li X: Downregulated CDK10 expression in gastric cancer:
Association with tumor progression and poor prognosis. Mol Med Rep.
17:6812–6818. 2018.PubMed/NCBI
|
|
18
|
Lin C, Xin S, Qin X, Li H, Lin L and You
Y: Zoledronic acid suppresses metastasis of esophageal squamous
cell carcinoma cells through upregulating the tight junction
protein occuludin. Cytotechnology. 68:1233–1241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
You Y, Yang W, Qin X, Wang F, Li H, Lin C,
Li W, Gu C, Zhang Y and Ran Y: ECRG4 acts as a tumor suppressor and
as a determinant of chemotherapy resistance in human nasopharyngeal
carcinoma. Cell Oncol (Dordr). 38:205–214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You Y, Li H, Qin X, Ran Y and Wang F:
Down-regulated ECRG4 expression in breast cancer and its
correlation with tumor progression and poor prognosis-a short
report. Cell Oncol (Dordr). 39:89–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
You Y, Li H, Qin X, Zhang Y, Song W, Ran Y
and Gao F: Decreased CDK10 expression correlates with lymph node
metastasis and predicts poor outcome in breast cancer patients-a
short report. Cell Oncol (Dordr). 38:485–491. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mertz KD, Mager LF, Wasmer MH, Thiesler T,
Koelzer VH, Ruzzante G, Joller S, Murdoch JR, Brümmendorf T,
Genitsch V, et al: The IL-33/ST2 pathway contributes to intestinal
tumorigenesis in humans and mice. Oncoimmunology. 5:e10629662015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dominguez D, Ye C, Geng Z, Chen S, Fan J,
Qin L, Long A, Wang L, Zhang Z, Zhang Y, et al: Exogenous IL-33
restores dendritic cell activation and maturation in established
cancer. J Immunol. 198:1365–1375. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haga Y, Yanagisawa K, Ohto-Ozaki H,
Tominaga S, Masuzawa T and Iwahana H: The effect of ST2 gene
product on anchorage-independent growth of a glioblastoma cell
line, T98G. Eur J Biochem. 270:163–170. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jovanovic IP, Pejnovic NN, Radosavljevic
GD, Pantic JM, Milovanovic MZ, Arsenijevic NN and Lukic ML:
Interleukin-33/ST2 axis promotes breast cancer growth and
metastases by facilitating intratumoral accumulation of
immunosuppressive and innate lymphoid cells. Int J Cancer.
134:1669–1682. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu XX, Hu Z, Shen X, Dong LY, Zhou WZ and
Hu WH: IL-33 promotes gastric cancer cell invasion and migration
Via ST2-ERK1/2 pathway. Dig Dis Sci. 60:1265–1272. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun P, Ben Q, Tu S, Dong W, Qi X and Wu Y:
Serun interleukin-33 levels in patients with gastric cancer. Dig
Dis Sci. 56:3596–3601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmieder A, Multhoff G and Radons J:
Interleukin-33 acts as a pro-inflammatory cytokine and modulates
its receptor gene expression in highly metastatic human pancreatic
carcinoma cells. Cytokine. 60:514–521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Levescot A, Flamant S, Basbous S, Jacomet
F, Féraud O, Anne Bourgeois E, Bonnet ML, Giraud C, Roy L, Barra A,
et al: BCR-ABL-induced deregulation of the IL-33/ST2 pathway in
CD34+ progenitors from chronic myeloid leukemia patients. Cancer
Res. 74:2669–2676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qin L, Dominguez D, Chen S, Fan J, Long A,
Zhang M, Fang D, Zhang Y, Kuzel TM and Zhang B: Exogenous IL-33
overcomes T cell tolerance in murine acute myeloid leukemia.
Oncotarget. 7:61069–61080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bergis D, Kassis V, Ranglack A, Koeberle
V, Piiper A, Kronenberger B, Zeuzem S, Waidmann O and Radeke HH:
High serum levels of the interleukin-33 receptor soluble ST2 as a
negative prognostic factor in hepatocellular carcinoma. Transl
Oncol. 6:311–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
